✦ LIBER ✦

Reflex sympathetic dystrophy: Treatment with long-acting intramuscular corticosteroids

✍ Scribed by Arnis B. Grundberg

Book ID: 117504765
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 575 KB
Volume: 21
Category: Article
ISSN: 0363-5023
DOI: 10.1016/s0363-5023(96)80023-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of reflex sympathet

Successful treatment of reflex sympathetic dystrophy with gabapentin

✍ Larry B Mellick; Gary A Mellick 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Treatment of acute reflex sympathetic dy

Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty cream

✍ W. W. A. Zuurmond; P. N. J. Langendijk; P. D. Bezemer; H. E. J. Brink; J. J. de 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB

Behavioral rehabilitation of reflex symp

Behavioral rehabilitation of reflex sympathetic dystrophy dystrophy in an adolescent: A case study with long-term follow-up

✍ R.S. Roth 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 187 KB

One-year hospitalization rates in patien

One-year hospitalization rates in patients with schizophrenia during long-term treatment with long-acting intramuscular risperidone

✍ P. Chue; E. Devos; I. Duchesne; A. Leal; A. Mehnert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Reflex sympathetic dystrophy of the knee

Reflex sympathetic dystrophy of the knee following arthroscopic surgery: Successful treatment with neural blockade utilizing local anesthetics

✍ Steven D. Waldman; Katherine A. Waldman 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin